S&P 500 · Wednesday, July 1, 2026 · Target: +5% in 30 days
bullish
The market shows selective strength with notable momentum in semiconductors (AMAT +23.4%, AMD +11.8%), growth tech (APP +10.3%), and industrials. Weakness persists in energy, materials, and real estate, suggesting a bifurcated market favoring innovation and discretionary sectors.
Amphenol makes connectors and cables that link semiconductors and electronic systems together. With the semiconductor supply chain accelerating and AI infrastructure buildout, Amphenol has climbed 20% in 21 days and appears poised for another 5% gain.
Key Risks
Arch Capital is an insurance and reinsurance company with operations across property, casualty, and other lines. The stock is up 9.4% in 30 days with technical indicators aligned, outperforming the market by 10.9%, and insiders are buying, suggesting management confidence. Insurance stocks can be cyclical, and economic slowdown could pressure valuations.
Key Risks
Amgen is a large-cap biotech company producing innovative therapies and vaccines. The stock has climbed 10% in 30 days with healthy momentum and relative strength outperforming the market by 11.6%, while technical indicators remain in balanced territory. The main risk is that the biotech sector can be volatile during broader market shifts.
Key Risks
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by July 31, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.